Company performance
Add to research
Current Price
as of Feb 07, 2025$32.56
P/E Ratio
N/A
Market Cap
$3.63B
Description
Add to research
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVKTX
- Price$32.56+3.50%
Trading Information
- Market cap$3.63B
- Float96.34%
- Average Daily Volume (1m)4,583,280
- Average Daily Volume (3m)3,999,050
- EPS-$1.01
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$109.96M
- Gross marginN/A
- EBITDA marginN/A
- EBITDAN/A
- EV$3.49B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B4.13
- Debt/Equity0.13
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account